Cargando…

The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism

Detalles Bibliográficos
Autores principales:	Lazaros, George, Klein, Allan L., Hatziantoniou, Sophia, Tsioufis, Costas, Tsakris, Athanasios, Anastassopoulou, Cleo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275472/ https://www.ncbi.nlm.nih.gov/pubmed/34312010 http://dx.doi.org/10.1016/j.vaccine.2021.07.016

Ejemplares similares

Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: A pragmatic approach
por: Anastassopoulou, Cleo, et al.
Publicado: (2022)

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States
por: Lazaros, George, et al.
Publicado: (2021)

Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance
por: Maltezou, Helena C., et al.
Publicado: (2023)

The Role of Oral Antivirals for COVID-19 Treatment in Shaping the Pandemic Landscape
por: Anastassopoulou, Cleo, et al.
Publicado: (2022)

SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall
por: Anastassopoulou, Cleo, et al.
Publicado: (2020)

Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines
por: Maltezou, Helena C., et al.
Publicado: (2022)

Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes
por: Anastassopoulou, Cleo, et al.
Publicado: (2021)

Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data
por: Boufidou, Fotini, et al.
Publicado: (2023)

Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity
por: Anastassopoulou, Cleo, et al.
Publicado: (2020)

Pixel-Based Machine Learning and Image Reconstitution for Dot-ELISA Pathogen Diagnosis in Biological Samples
por: Anastassopoulou, Cleo, et al.
Publicado: (2021)

Data-based analysis, modelling and forecasting of the COVID-19 outbreak
por: Anastassopoulou, Cleo, et al.
Publicado: (2020)

Paired associated SARS-CoV-2 spike variable positions: a network analysis approach to emerging variants
por: Manoussopoulos, Yiannis, et al.
Publicado: (2023)

SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
por: Boufidou, Fotini, et al.
Publicado: (2023)

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
por: Bolze, Alexandre, et al.
Publicado: (2022)

Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods
por: Anastassopoulou, Cleo, et al.
Publicado: (2022)

Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach
por: Russo, Lucia, et al.
Publicado: (2020)

Epidemiological Transition and Strategies for the Control of Hepatitis A in Serbia
por: Medić, Snežana, et al.
Publicado: (2023)

Diagnosis of Acute Myocarditis Following mRNA Vaccines against SARS-CoV-2: A Methodological Review
por: Zuin, Marco, et al.
Publicado: (2023)

New Insights into the Molecular Interplay between Human Herpesviruses and Alzheimer’s Disease—A Narrative Review
por: Athanasiou, Evita, et al.
Publicado: (2022)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis?
por: Shahid, Rida, et al.
Publicado: (2023)

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
por: Weintraub, Eric S., et al.
Publicado: (2022)

Acute Pericarditis: Update
por: Lazarou, Emilia, et al.
Publicado: (2022)

mRNA vaccines: A matter of delivery
por: Cao, Yuhong, et al.
Publicado: (2021)

Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia
por: Medić, Snežana, et al.
Publicado: (2023)

Cholesterol pericarditis following COVID-19 vaccination
por: Lazarou, Emilia, et al.
Publicado: (2023)

The Role of Nutrition in Cardiovascular Disease: Current Concepts and Trends
por: Tyrovola, Dimitra, et al.
Publicado: (2023)

mRNA-1273: Myocarditis: case report
Publicado: (2021)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 mRNA Vaccine and Myocarditis
por: Singh, Balraj, et al.
Publicado: (2021)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Post‐COVID myocarditis with antiheart antibodies persistence: Clues for autoimmunity?
por: Silva, Lucas S., et al.
Publicado: (2023)

Environmental testing for SARS-CoV-2 in three tertiary-care hospitals during the peak of the third COVID-19 wave
por: Maltezou, Helena C., et al.
Publicado: (2021)

Medical emergency teams: deciphering clues to crises in hospitals
por: DeVita, Michael
Publicado: (2005)

Myocarditis Associated with mRNA COVID-19 Vaccination
por: Starekova, Jitka, et al.
Publicado: (2021)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

Myocarditis following COVID-19 mRNA vaccination
por: Parmar, Kanak, et al.
Publicado: (2021)

COVID-19 mRNA Vaccine-Associated Myocarditis
por: Kyaw, Htin, et al.
Publicado: (2022)

Myocarditis following COVID-19 mRNA vaccination
por: Abu Mouch, Saif, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0vqp2e9076emd83mju1t4e8fo